Free Trial
Matthew Hewitt

Matthew Hewitt Analyst Performance

Senior Research Analyst at Craig Hallum

Matthew Hewitt is a stock analyst at Craig Hallum focused in the medical sector, covering 4 publicly traded companies. Over the past year, Matthew Hewitt has issued 5 stock ratings, including buy and hold recommendations. While full access to Matthew Hewitt's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Matthew Hewitt's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
6 Last 4 Years
Buy Recommendations
83.33% 5 Buy Ratings
Companies Covered
4 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy83.3%5 ratings
Hold16.7%1 ratings
Sell0.0%0 ratings

Out of 6 total stock ratings issued by Matthew Hewitt at Craig Hallum, the majority (83.3%) have been Buy recommendations, followed by 16.7% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
4 companies

Matthew Hewitt, an analyst at Craig Hallum, currently covers 4 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
3 companies
75.0%
Transportation
1 company
25.0%

Matthew Hewitt of Craig Hallum specializes in stock coverage within the Medical sector, with additional focus on Transportation companies.

Coverage Industries

IndustryPercentage
TRANS - SERVICES
1 company
25.0%
MED PRODUCTS
1 company
25.0%
MED - BIOMED/GENE
1 company
25.0%
MED - DRUGS
1 company
25.0%

About Matthew Hewitt

Matt has over 15 years experience at Craig-Hallum covering the life science tools/services, health care technology/services and medical device industries. Thomson Reuters recognized him as the #1 stock picker for healthcare technology in 2018. Previously, he worked in the internet services, software and computer peripherals research practice at Craig-Hallum and spent seven years at Advantus Capital Management. Matt received his BA and MBA from the University of St. Thomas.

Matthew Hewitt's Ratings History at Craig Hallum

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
CryoPort, Inc. stock logo
CYRX
CryoPort
3/30/2026Initiated Coverage$7.96$15.00Buy
Apyx Medical Corporation stock logo
APYX
Apyx Medical
3/11/2026Boost Price Target$3.89$6.00Buy
Certara, Inc. stock logo
CERT
Certara
2/27/2026Downgrade$6.80$10.00Hold
Certara, Inc. stock logo
CERT
Certara
9/29/2025Initiated Coverage$11.80$16.00Buy
Certara, Inc. stock logo
CERT
Certara
9/29/2025Initiated Coverage$12.22$16.00Buy